These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25856305)

  • 41. Unilamellar vesicles as potential capreomycin sulfate carriers: preparation and physicochemical characterization.
    Giovagnoli S; Blasi P; Vescovi C; Fardella G; Chiappini I; Perioli L; Ricci M; Rossi C
    AAPS PharmSciTech; 2004 Dec; 4(4):E69. PubMed ID: 15198564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics.
    Chen CC; Tsai TH; Huang ZR; Fang JY
    Eur J Pharm Biopharm; 2010 Mar; 74(3):474-82. PubMed ID: 20060469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The use of pH-triggered leaky heterogeneities on rigid lipid bilayers to improve intracellular trafficking and therapeutic potential of targeted liposomal immunochemotherapy.
    Karve S; Alaouie A; Zhou Y; Rotolo J; Sofou S
    Biomaterials; 2009 Oct; 30(30):6055-64. PubMed ID: 19665223
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Large-scale manufacturing of GMP-compliant anti-EGFR targeted nanocarriers: production of doxorubicin-loaded anti-EGFR-immunoliposomes for a first-in-man clinical trial.
    Wicki A; Ritschard R; Loesch U; Deuster S; Rochlitz C; Mamot C
    Int J Pharm; 2015 Apr; 484(1-2):8-15. PubMed ID: 25701632
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fusion-dependent formation of lipid nanoparticles containing macromolecular payloads.
    Kulkarni JA; Witzigmann D; Leung J; van der Meel R; Zaifman J; Darjuan MM; Grisch-Chan HM; Thöny B; Tam YYC; Cullis PR
    Nanoscale; 2019 May; 11(18):9023-9031. PubMed ID: 31021343
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir.
    Seyfoddin A; Al-Kassas R
    Drug Dev Ind Pharm; 2013 Apr; 39(4):508-19. PubMed ID: 22424312
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessing the heterogeneity level in lipid nanoparticles for siRNA delivery: size-based separation, compositional heterogeneity, and impact on bioperformance.
    Zhang J; Pei Y; Zhang H; Wang L; Arrington L; Zhang Y; Glass A; Leone AM
    Mol Pharm; 2013 Jan; 10(1):397-405. PubMed ID: 23210488
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of PEGylated nanoliposomes co-remotely loaded with topotecan and vincristine: relating structure and pharmacokinetics to therapeutic efficacy.
    Zucker D; Andriyanov AV; Steiner A; Raviv U; Barenholz Y
    J Control Release; 2012 Jun; 160(2):281-9. PubMed ID: 22019556
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems.
    Kraft JC; Freeling JP; Wang Z; Ho RJ
    J Pharm Sci; 2014 Jan; 103(1):29-52. PubMed ID: 24338748
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of a weak-base docetaxel derivative that can be loaded into lipid nanoparticles.
    Zhigaltsev IV; Winters G; Srinivasulu M; Crawford J; Wong M; Amankwa L; Waterhouse D; Masin D; Webb M; Harasym N; Heller L; Bally MB; Ciufolini MA; Cullis PR; Maurer N
    J Control Release; 2010 Jun; 144(3):332-40. PubMed ID: 20202473
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Feasibility of haloperidol-anchored albumin nanoparticles loaded with doxorubicin as dry powder inhaler for pulmonary delivery.
    Varshosaz J; Hassanzadeh F; Mardani A; Rostami M
    Pharm Dev Technol; 2015 Mar; 20(2):183-96. PubMed ID: 24219091
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cationic liposomes loaded with doxorubicin targeting to the tumor neovasculature in vitro].
    Zhao W; Ma HL; Qi XR
    Yao Xue Xue Bao; 2007 Sep; 42(9):982-8. PubMed ID: 18050743
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bisphosphonate-decorated lipid nanoparticles designed as drug carriers for bone diseases.
    Wang G; Mostafa NZ; Incani V; Kucharski C; Uludağ H
    J Biomed Mater Res A; 2012 Mar; 100(3):684-93. PubMed ID: 22213565
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Doxorubicin-loaded lipid-quantum dot hybrids: surface topography and release properties.
    Tian B; Al-Jamal WT; Al-Jamal KT; Kostarelos K
    Int J Pharm; 2011 Sep; 416(2):443-7. PubMed ID: 21315141
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Archaeosomes as carriers for topical delivery of betamethasone dipropionate: in vitro skin permeation study.
    González-Paredes A; Manconi M; Caddeo C; Ramos-Cormenzana A; Monteoliva-Sánchez M; Fadda AM
    J Liposome Res; 2010 Dec; 20(4):269-76. PubMed ID: 19954402
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Physicochemical characterization by AFM, FT-IR and DSC and biological assays of a promising antileishmania delivery system loaded with a natural Brazilian product.
    Marquele-Oliveira F; Torres EC; Barud Hda S; Zoccal KF; Faccioli LH; Hori JI; Berretta AA
    J Pharm Biomed Anal; 2016 May; 123():195-204. PubMed ID: 26897464
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
    Das S; Ng WK; Tan RB
    Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies.
    Nallamothu R; Wood GC; Kiani MF; Moore BM; Horton FP; Thoma LA
    PDA J Pharm Sci Technol; 2006; 60(3):144-55. PubMed ID: 17089683
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Triggered liposomal release through a synthetic phosphatidylcholine analogue bearing a photocleavable moiety embedded within the sn-2 acyl chain.
    Bayer AM; Alam S; Mattern-Schain SI; Best MD
    Chemistry; 2014 Mar; 20(12):3350-7. PubMed ID: 24615893
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Microfluidic directed self-assembly of liposome-hydrogel hybrid nanoparticles.
    Hong JS; Stavis SM; DePaoli Lacerda SH; Locascio LE; Raghavan SR; Gaitan M
    Langmuir; 2010 Jul; 26(13):11581-8. PubMed ID: 20429539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.